Filing Flows › AstraZeneca (AZN) › Farxiga revenue
AstraZeneca (AZN) Farxiga revenue by quarter
AstraZeneca's Farxiga revenue was $1.6B in Q3 2026 (third quarter 2026), -27% from Q1 2026. Over the last 3 quarters it ranged from $1.6B (Q3 2026) to $2.2B (Q1 2026).
| Quarter | Farxiga revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.6B | -27% | — |
| Q1 2026 | $2.2B | +13% | — |
| Q4 2024 | $1.9B | — | — |
Q3 2026 at a glance
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is AstraZeneca's Farxiga revenue?
AstraZeneca's Farxiga revenue was $1.6B in Q3 2026 (third quarter 2026), -27% from Q1 2026.
How has AstraZeneca's Farxiga revenue changed?
Over the last 3 quarters it ranged from $1.6B (Q3 2026) to $2.2B (Q1 2026).